Warning! GuruFocus detected
2 Severe warning signs
with MED.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NYSE:MED Key Ratios
| Market Cap $ M | 132.40 |
| Enterprise Value $ M | -13.54 |
| P/E(ttm) | 67.25 |
| PE Ratio without NRI | 110.05 |
| Forward PE Ratio | 40.30 |
| Price/Book | 0.63 |
| Price/Sales | 0.22 |
| Price/Free Cash Flow | 7.77 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 602.00 |
| EPS (TTM) $ | 0.18 |
| Beneish M-Score | -3.07 |
| 10-y EBITDA Growth Rate % | 11.20 |
| 5-y EBITDA Growth Rate % | -21.30 |
| y-y EBITDA Growth Rate % | -88.90 |
| EV-to-EBIT | -4.70 |
| EV-to-EBITDA | -0.87 |
| PEG | -- |
| Shares Outstanding M | 10.94 |
| Net Margin (%) | 0.35 |
| Operating Margin % | 0.48 |
| Pre-tax Margin (%) | 0.63 |
| Quick Ratio | 2.68 |
| Current Ratio | 3.34 |
| ROA % (ttm) | 0.71 |
| ROE % (ttm) | 1.01 |
| ROIC % (ttm) | 1.96 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.75 |
MED Number of Guru Trades
MED Volume of Guru Trades
Gurus Latest Trades with NYSE:MED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:MED is held by these investors
Total 1
Medifast Inc Insider Transactions
No Available Data
News about NYSE:MED
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers